Programs and processes for advancing pediatric acute kidney support therapy in hospitalized and critically ill children: a report from the 26th Acute Disease Quality Initiative (ADQI) consensus conference.

"Declarations Conflict of interestAll authors declare no real or perceived conflicts of interest affecting study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication. For full disclosure, we provide here an additional list of author commitments and funding sources that are not directly related to this study: D.J.A. is a consultant for Baxter, Nuwellis, Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from the National Institutes of Health, Baxter, Nuwellis, Medtronic, Bioporto, Portero, and Leadiant. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow, Inc. J.M. is a consultant for Medtronic. Conflict of interest All authors declare no real or perceived conflicts of interest affecting study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication. For full disclosure, we provide here an additional list of author commitments and funding sources that are not directly related to this study: D.J.A. is a consultant for Baxter, Nuwellis, Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from the National Institutes of Health, Baxter, Nuwellis, Medtronic, Bioporto, Portero, and Leadiant. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow, Inc. J.M. is a consultant for Medtronic."

"Declarations: Conflict of interestAll authors declare no real or perceived conflicts of interest affecting study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication. For full disclosure, we provide here an additional list of author commitments and funding sources that are not directly related to this study: D.J.A. is a consultant for Baxter, Nuwellis, Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from the National Institutes of Health, Baxter, Nuwellis, Medtronic, Bioporto, Portero, and Leadiant. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow, Inc. J.M. is a consultant for Medtronic. Conflict of interest: All authors declare no real or perceived conflicts of interest affecting study design, collection, analysis, and interpretation of data, writing of the report, or the decision to submit for publication. For full disclosure, we provide here an additional list of author commitments and funding sources that are not directly related to this study: D.J.A. is a consultant for Baxter, Nuwellis, Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from the National Institutes of Health, Baxter, Nuwellis, Medtronic, Bioporto, Portero, and Leadiant. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow, Inc. J.M. is a consultant for Medtronic."